Supplementary File 1
Supplementary Figure 1. Patients with ≥1 adverse event.
Supplementary Figure 2. Patients with ≥1 treatment-related adverse
event.
Supplementary Figure 3. Patients with ≥1 severe adverse event.
Supplementary Figure 4. Patients with ≥1 serious adverse event.
Supplementary Figure 5. Patients who stopped treatment due to adverse
event.
Supplementary Figure 6. Patients with urinary tract infection.
Supplementary Figure 7. Patients with vulvovaginal candidiasis.
Supplementary Figure 8. Patients with treatment-related vulvovaginal
candidiasis.